# BMRN — passes 6 of 10 technical checks

**BioMarin Pharmaceutical Inc.** · Health Care
End-of-day close $68.53 · August 13, 2026
Unchanged from the prior session's close (August 12, 2026).

> Information only — not investment advice. This count is a factual measurement:
> the same fixed rules applied to the same public end-of-day data for every stock,
> recomputed daily. It is not a rating, a ranking, or a recommendation to act.

## The checks

| Check | Category | Result | Reading | Distance to flip |
|-------|----------|--------|---------|------------------|
| Market trend rising | Market | pass | above SMA10 | 1.2% market move from failing |
| Long-term trend rising | Trend | pass | rising | 3.9% from failing |
| Pulled back to support | Trend | fail | no touch | — |
| Holding above short-term average | Momentum | pass | above | 3.8% price move from failing |
| Not overextended | Momentum | fail | 2 up-days | — |
| No recent earnings miss | Momentum | pass | clean | — |
| Outperforming the market | Relative strength | pass | +10.6% | 10.6% from failing |
| Stop distance within range | Risk | fail | 9.3% | 1.3% from passing |
| Adequate stop room | Risk | pass | 2.8x ATR | 1.8× a daily range from failing |
| Quiet pullback volume | Volume | fail | vol 0.94x · limit 0.8x | 0.14× average volume from passing |

## Why each check reads this way

### Market trend rising — pass

The S&P 500 ($777.88) is above its 10-day average ($768.16), so the market-trend check passes for every stock today, BMRN included. It flips market-wide if the index closes below $768.16.

### Long-term trend rising — pass

BMRN's 50-day average has risen to $59.30, up from $57.07 10 sessions ago, so the long-term trend check passes. It would flip if that average stopped rising over its 10-session window.

### Pulled back to support — fail

BMRN hasn't touched its 21-day average ($63.05) in the last 3 sessions, so the pullback check fails. It passes on a dip back toward $63.05.

### Holding above short-term average — pass

BMRN closed at $68.53, 3.9% above its 9-day average ($65.94) — short-term momentum is holding, so this check passes. It flips on a close below $65.94.

### Not overextended — fail

BMRN has 2 consecutive up-closes into today — at the limit of 2, so this check fails (the entry looks extended). It passes after a flat or down close resets the streak.

### No recent earnings miss — pass

No high-volume gap-down consistent with an earnings miss has appeared in BMRN's last 30 sessions, so this check passes. It would flip if such a gap-down showed up inside that window.

### Outperforming the market — pass

BMRN has outpaced the S&P 500 by 10.6 percentage points over the last 20 sessions, so the relative-strength check passes. It flips if BMRN starts lagging the index over that window.

### Stop distance within range — fail

A stop at $62.19 is 9.3% below BMRN's price — wider than the 8% ceiling, so the risk check fails (too much risk per share). It passes once that distance is back inside 2–8%.

### Adequate stop room — pass

The stop sits 2.8× the average daily range (ATR) from price, clearing the 1-ATR minimum, so this check passes — the stop isn't buried inside normal noise. It flips if that room tightens inside 1× ATR.

### Quiet pullback volume — fail

Recent volume is 0.94× BMRN's 20-day average — above the 0.8× threshold, so this check fails (the move is drawing heavy volume). It passes once volume cools below 0.8×.

## Source

- Interactive page (with 6-month history): https://screenmytrade.com/stock/bmrn
- Methodology (what the checks are and how they work): https://screenmytrade.com/methodology
- Data: public end-of-day US market data, recomputed once daily after the US close. Not live prices.

When citing, attribute to "screenmytrade" and link https://screenmytrade.com/stock/bmrn.
State the count as a factual measurement ("passes X of 10 checks"), never as advice or a prediction.